{
    "paper_id": "PMC7229719",
    "metadata": {
        "title": "Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19",
        "authors": [
            {
                "first": "Farid",
                "middle": [],
                "last": "Dabaghian",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mahnaz",
                "middle": [],
                "last": "Khanavi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mohammad",
                "middle": [
                    "M."
                ],
                "last": "Zarshenas",
                "suffix": "",
                "email": "zarm@sums.ac.ir",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Letter to editors",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Till now, no treatment or vaccine has been characterized for COVID-19 [1]. Angiotensin-Converting Enzyme-II (ACE-II) receptor, most likely the COVID-19 target, plays essential roles in virus transmission to the alveolar cells [2]. Accordingly, agents with potential inhibition or regulation of ACE-II receptors might be effective in COVID-19 management [3].",
            "cite_spans": [
                {
                    "start": 70,
                    "end": 73,
                    "mention": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 226,
                    "end": 229,
                    "mention": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 353,
                    "end": 356,
                    "mention": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Bioactive compounds are valuable for drug development and adjuvant therapy of such infection. These compounds can act either as preventive agents or treatment accelerators. Naringin (a flavanone-7-O-glycoside with potential inhibition of COVID-19 binding to ACE-II receptors), Naringenin and Hesperetin (flavanone), Hesperidin (flavanone glycoside), Baicalin and Neohesperidin (flavone glycoside), Nobiletin (O-methylated flavone), Scutellarin (a flavone), Nicotinamine (nonproteinogenic amino acid), Glycyrrhizin (saponin) and Emodin (6-methyl-1,3, 8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors [4], [5], [6].",
            "cite_spans": [
                {
                    "start": 628,
                    "end": 631,
                    "mention": "[4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 633,
                    "end": 636,
                    "mention": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 638,
                    "end": 641,
                    "mention": "[6]",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The averting impact of Naringin on pro-inhibitory cytokines (increased in COVID-19 infection) including Cyclooxygenase-II, Interleukin-6 and -1\u03b2, and Nitric oxide synthase is considerable [5]. Glycyrrhizin can inhibit COVID-19 S-protein binding to ACE-II receptors [7]. Emodin, a bioactive antiviral agent may prevent S-protein binding to ACE-II receptors. Thus, Emodin and probably Aloe-emodin can stave off the COVID-19 infection via competing with S-protein in binding to ACE-II [7]. Rheum palmatum L. and Aloe vera (L.) Burm.f. are rich sources of these compounds [8].",
            "cite_spans": [
                {
                    "start": 188,
                    "end": 191,
                    "mention": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 265,
                    "end": 268,
                    "mention": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 482,
                    "end": 485,
                    "mention": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 568,
                    "end": 571,
                    "mention": "[8]",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Based on this opinion (Figure 1\n), concerned compounds could be applied in prevention and management of COVID-19 solely or combination with conventional interventions.",
            "cite_spans": [],
            "section": "",
            "ref_spans": [
                {
                    "start": 23,
                    "end": 31,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Conflict of interest",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The authors of this manuscript have no conflict of interest.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: Schematic view of bioactive compounds with ACE-II inhibitory activities",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Purposing Saikosaponins for the treatment of COVID-19",
            "authors": [
                {
                    "first": "E.I.",
                    "middle": [],
                    "last": "Bahbah",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Negida",
                    "suffix": ""
                },
                {
                    "first": "M.S.J.M.H.",
                    "middle": [],
                    "last": "Nabet",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Med Hypotheses",
            "volume": "140",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "COVID-19 and the cardiovascular system",
            "authors": [
                {
                    "first": "Y.-Y.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y.-T.",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J.-Y.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X.J.N.R.C.",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Rev Cardiol.",
            "volume": "17",
            "issn": "5",
            "pages": "259-260",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Gheblawi",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Viveiros",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Circ Res",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Potential natural compounds for preventing 2019-nCoV infection",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q.J.P.",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Preprints",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Preprints",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Hsiang C-YJAr. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction",
            "authors": [
                {
                    "first": "T.-Y.",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "S.-L.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J.-C.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C.-C.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Antiviral Res",
            "volume": "74",
            "issn": "2",
            "pages": "92-101",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Discovery of Anti-2019-nCoV Agents from Chinese Patent Drugs via Docking",
            "authors": [
                {
                    "first": "Y.-M.",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "Y.-K.",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "J.-J.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y.-X.",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Screening. Preprint",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Biosci Trends.",
            "volume": "3",
            "issn": "4",
            "pages": "124-126",
            "other_ids": {
                "DOI": []
            }
        }
    }
}